Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis.
Liu Q, Yu J, Wang L, Tang Y, Zhou Q, Ji S, Wang Y, Santos L, Haeusler RA, Que J, Rajbhandari P, Lei X, Valenti L, Pajvani UB, Qin J, Qiang L.
Liu Q, et al. Among authors: qiang l.
J Hepatol. 2020 Aug;73(2):361-370. doi: 10.1016/j.jhep.2020.02.025. Epub 2020 Mar 3.
J Hepatol. 2020.
PMID: 32135178